Immunohistochemical and Molecular Characterization of the Differential Response of the Rat Mesenteric Microvasculature to Angiotensin-II Infusion

Journal of Vascular Research

Volumn 33, Issue 3, 1996, Pages 195-208

  Wiener, Joseph ^a   Lombardi, Donna M ^b   Su, Joe E ^b   Schwartz, Stephen M ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Angiotensin II; Elastin; Gene expression; Hypertension; In situ hybridization; Mesenteric resistance arteries; Osteopontin; Polyploidy; Vascular remodeling; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; ELASTIN; OSTEOPONTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL INJURY; CELL INFILTRATION; CONTROLLED STUDY; DNA SYNTHESIS; FIBROSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; MESENTERIC ARTERY; MICROSCOPY; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR RESISTANCE;

EID: 0029901412     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159148     Document Type: Article

References (65)

1. Giacomelli F, Rooney J, Wiener J: Cerebrovascular ultraslructure and permeability after carotid artery constriction in experimental hypertension, Exp Mol Pathol 1978:28:309-321.
2. Bhan RD, Giacomelli F, Wiener J: Adrenore-ceptor blockade in angiotensin-induced hypertension, Effect on rat coronary arteries and myocardium, Am J Pathol 1982:108:60-71.
3. Dzau VJ: Molecular and physiological aspects of tissue renin-angiotensin system: Emphasis on cardiovascular control, J Hypertens 1988: 6(suppl 3):7-11.
4. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM: Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall, Circ Res 1991:68:450-456.
5. Gcisterfcr AMJ, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells, Circ Res 1988:62:749-756.
6. Gibbons GH, Pratt RE, Dzau VJ: Vascular smooth muscle cell hypertrophy vs, hyperplasia, Autocrine transforming growth factor-Bj expression determines growth response to angiotensin II, J Clin Invest 1992:90:456-461.
7. Powell JS, Clozel J-P, Muller RK, Kuhn 11. Hefti F, Hosang M, Baumgartner HR: Inhibitors of angiotensin-converting enzyme prevent myointima! proliferation after vascular injury, Science 1989:245:186-188.
8. Koletsky S, Rivera-Velez JM, Pritchard WH: Production of hypertension and vascular disease by angiotensin, Arch Pathol 1966:82:99-106.
9. Hall JE, Guyton AC, Salgado HC, McCaa RE, Balfe JW: Renal hemodynamics in acute and chronic angiotensin II hypertension, Am J Physiol 1978:235:F174-F179.
10. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM: Renal injury from angiotensin II-mediatcd hypertension, Hypertension 1992:19:464-474.
11. Lombardi DM, Owens GK, Schwartz SM: Ploidv in mesenteric vessels of aged spontaneously hypertensive and Wistar-Kyoto rats, Hypertension 1989:13:475-479.
12. Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM: Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication, Exp Cell Res 1989:168:475-486.
13. Dijkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies EDI, ED2 and ED3. Immunology 1985;54:589-599.
14. Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D: Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization, J Clin Ivest 1988:82:1134-1143.
15. Giachelli CM, Bac N, Lombardi DM, Majcsky MW, Schwartz SM: Molecular cloning and characterization of 2B7. a rat mRNA which distinguishes smooth muscle phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein 1. 2ar), Biochem Biophvs Res Commun 1991:177:867-873.
16. Majesky MW, Giachelli CM, Reidy MA, Schwartz SM: Rat carotid neointimal smooth muscle cells rc-expresss a developmentally regulated mRNA phenotype during repair of arterial injury, Circ Res 1992;71:759-768.
17. Connolly KM, BogdanlTv MS: Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: A dual-stain comparison with 5-bromo-2'-dcoxyuridine, J Histochem Cytochem 1993; 41:1-6.
18. Owens GK, Rabinovitch PS, Schwartz SM: Smooth muscle cell hypertrophy versus hyperplasia in hypertension, Proc Natl Acad Sci USA 1981:78:7759-7763.
19. Owens GK, Schwartz SM: Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat, Role of cellular hypertrophy, hyperploidy, and hyperplasia, Circ Res 1982: 51:280-289.
20. Owens GK: Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat, Circ Res 1985:56:525-536.
21. Owens GK: Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats, Hypertension 1987:91:178-187.
22. Lee RMKW, Smeda JS: Primary versus secondary structural changes of the blood vessels in hypertension, Can J Phvsiol Pharmacol 1985:63:392-401.
23. Lee RMKW: Structural alterations of blood vessels in hypertensive rats, Can J Physiol Pharmacol 1987;65:1528-1535.
24. Mano M, Nara Y, Tsubouchi T, Horie R, Yamori Y: Effect of noradrenaline exposure on polyploidy formation in cultured smooth muscle cells from normotensive Wistar-Kyoto rats, J Hypertens 1986;4(suppl 3): 113-114.
25. Yamori Y, Mano M, Nara Y, Horie R: Catecholamine-induced polyploidization in vascular smooth muscle cells, Circulation 1987; 75(suppl 1):92-95.
26. Chobanian AV, Lichtenstein AH, Schwartz JH, Hanspal J, Brecher P: Effects of deoxycorticosterone/salt hypertension on cell ploidy in rat aortic smooth muscle cells, Circulation 1987:75(suppl 1):102-106.
27. Devlin AM, Gordon JF, Davidson AO, Clark JS, Hamilton CA, Morton JJ, Campbell AM, Reid JL, Dominiczak AF: The effects of perin-dopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats, J Hypertens 1995; 13:211-218.
28. Gordon D, Mohai LG, Schwartz SM: Induction of polyploidy in cultures of neonatal rat aortic smooth muscle cells, Circ Res 1986:59: 633-644.
29. Black MJ, Campbell JH, Campbell GR: Does smooth muscle cell polyploidy occur in resistance vessels of spontaneously hypertensive rats? Blood Vessels 1988:25:89-100
30. Owens GK, Schwartz SM, McCanna M: Evaluation of medial hypertrophy in resistance vessels of spontaneously hypertensive rats, Hypertension 1988; 11:198-207.
31. Brown LF, Berse B, Van De Water L, Papado-polous-Sergio A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR: Expression and distribution of osteopontin in human tissues: Widespread association with luminal epithelial surfaces, Mol Biol Cell 1992:3:1169-1180
32. Heinegarol D, Hultenbv A, Oldberg A, Rcin-holt A, Wcndel M: Macromolecules in bone matrix, Connect Tissue Res 1989;21:3-11.
33. Butler WT: The nature and significance of osteopontin, Connect Tissue Res 1989:23:123-136.
34. Patarca R, Freeman GJ, Singh RP, Wei F-Y, Durfce T, Blattner F, Regnicr DC, Kozak CA, Mock BA, Morse HC III, Jarrelis TR, Cantor H: Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene: Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infec-tion, JExpMed 1989:170:145-161.
35. Lampc MA, Patarca R, Iregiu MV, Cantor H: Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease, J Immunol 1991:147:2902- 2906.
36. Craig AM, Nemir M, Mukhcrjee BB, Chambers AF, Denhardt DT: Identification of the major phosphoprotein secreted by many rodent cell lines as 2 ar/osteopontin: Enhanced expression in H-ras-transformed 3T3 cells, Bio-chem Biophys Res Commun 1989; 157:166-173.
37. Senger DR, Perruzzi Ca, Papadopolous A: Elevated expression of secreted phosphoprotein 1 (osteopontin, 2ar) as a consequence of neoplastic transformation, Anticanccr Res 1989:9: 1291-1299.
38. Fet V, Dickinson ME, Hogan BIM: Localization of the mouse gene for the secreted phosphoprotein I (Spp-1) (2ar, osteopontin, bone sialoprotein 1. 44-kDa bone phosphoprotein, tumor-secreted phosphoprotein) to chromosome 5. closely linked to Ric (Rickettsia resistance), Genomics 1989;5:375-377.
39. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM: Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques, J Clin Invest 1993;92: 1686-1696.
40. Bahadori L, Milder J, Gold I, Botney M: Active macrophage-associated TGF-β co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries, Am J Pathol 1995;146:1140-1149.
41. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ: Tubulointerstitial disease in glomerulonephritis, Potential role of ostcopontin (uro-ponlin), AmJ Pathol 1994;144:915-926.
42. Singh R P, Patarca R, Schwartz J, Singh P, Cantor H: Definition of a specific interaction between the early T lymphocyte activation (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo, J Exp Med 1990;171:1931-1942.
43. Schmidt JA, Mizel SB, Cohen D, Green I: Interleukin I, a potential regulator of fibroblast proliferation, J Immunol 1982;128:2177-2182.
44. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Shepard HM: Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro, Science 1985;230:943-945.
45. Vilcek J, Palombclla VJ, Hcnriksen-DeStefano D, Swenson C, Feinman R, Hirai M, Tsujimo-to M: Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors, J Exp Med 1986;163:632-643.
46. Wiener J, Loud AV, Giacomclli F, Anversa P: Morphometric analysis of hypertension induced hypertrophy of rat thoracic aorta, Am J Pathol 1977:88:619-634.
47. Wolinskv H: Response of the rat aortic media to hypertension: Morphological and chemical studies, Circ Res 1971;26:507-522.
48. Wolinsky H: Long term effects of hypertension on the rat aortic wall and their relation to concurrent aging changes, Circ Res 1972:30:301-309.
49. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium, Fibrosis and re-nin-angiotensin-aldosteronc system, Circulation 1991:83:1849-1865.
50. Linz W, Schapcr J, Wicmcr G, Albus U, Scholkens BA: Ramipri! prevents left ventricular hvpcrthropy with myocardial fibrosis without blood pressure reduction: A one year study in rats, Br J Pharmacol 1992:107:970-975.
51. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM: Angiotensin II is mito-genic in neonatal rat cardiac fibroblasts, Circ Res 1993:72:1245-1254.
52. Sadoshima J, Izumo S: Molecular characterization of angiotensin Il-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts, Critical role of the ATi receptor subtype, Circ Res 1993:73:413-423.
53. Farivar RS, Crawford DC, Chobanian AV, Brechcr P: Effect of angiotensin II blockade on the fibroprolifcrative response to phenylephrine in the rat heart, Hypertension 1995:25: 809-813.
54. Ashizawa N, Do YS, Giachelli C, Anderson PW, Quinones M, Hsueh WA: Osteopontin mRNA is uprcgulated in cardiac hypertrophy and is enhanced by angiotensin II in cardiac fibroblasts (abstract), Hypertension 1995:26: 561.
55. Contard F, Sabri A, Glukhova M, Sartorc S, Marotlc F, Pomies JP, Schiavi P, Guez D, Samuel J-L, Rappaport L: Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats, Hypertension 1993; 22:665-676.
56. Wiener J, Giacomelli F: The cellular pathology of experimental hypertension, VII, Structure and permeability of the mesenteric vasculature in angiotensin-induced hypertension, Am J Pathol 1973;72:221-240.
57. Folkow B: Physiological aspects of primary hypertension, Physiol Res 1982:62:347-504.
58. Korsgaard N, Mulvany JM: Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats, Hypertension 1988; 12:162-167.
59. Griffin SA, Brown WCB, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany JM, Lever AF: Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism, Hypertension 1991:17:626-635.
60. Mulvany MJ, Baandrup U, Gundcrsen HJG: Evidence for hyperplasia in mesenteric resis tance vessels of spontaneously hypertensive rats using a three-dimensional dissector, Circ Res 1985:57:794-800.
61. Korsgaard N, Aalkjer C, Heagerty AM, Izzard AS, Mulvany MJ: Histology of subcutaneous small arteries from patients with essential hypertension, Hypertension 1993:22:523-526.
62. Thybo NK, Korsgaard N, Mulvany MJ, Morphology and function of mesenteric resistance arteries in transgenic rats with low renin hypertension, J Hvpertens 1992:10:1191-1196.
63. Bauntbach GL, Heistad DD: Remodeling of cerebral arterioles in chronic hypertension, Hypertension 1989; 13:968-972.
64. Wiener J, Lattes RG, Mcltzcr BG, Spiro D: The cellular pathology of experimental hypertension, IV, Evidence for increased vascular permeability, Am J Pathol 1969:55:295-327.
65. Giacomclli F, Wiener J, Spiro D: The cellular pathology of experimental hypertension, V, Increased permeability of cerebral arterial vessels, Am J Pathol 1970:59:133-159.